18
Jul
Management Of Benign Prostatic Hyperplasia. Presents with both storage symptoms frequency urgency nocturia and incontinence and voiding. Management of benign prostatic hyperplasia. The aetiology of benign prostatic hyperplasia is multi factorial involving smooth muscle hyperplasia prostatic enlargement and bladder dysfunction as well as input from the central nervous system. Treatment for bph has long been medications and procedures such as lasers or an electric loop which burn the prostate from the inside out.
The aetiology of benign prostatic hyperplasia is multi factorial involving smooth muscle hyperplasia prostatic enlargement and bladder dysfunction as well as input from the central nervous system. The diagnosis of bph hinges on a thorough medical history and focused physical examination with attention to other conditions that may be. This common clinical problem is diagnosed by history including the international prostate symptom score ipss questionnaire and physical examination by digital rectal examination dre. Treatment for bph has long been medications and procedures such as lasers or an electric loop which burn the prostate from the inside out. Benign prostatic hyperplasia bph and associated lower urinary tract symptoms luts commonly affect older men. But now a relatively new convective water therapy treatment uses steam to make the prostate smaller.
Benign prostatic hyperplasia bph and associated lower urinary tract symptoms luts commonly affect older men.
The aetiology of benign prostatic hyperplasia is multi factorial involving smooth muscle hyperplasia prostatic enlargement and bladder dysfunction as well as input from the central nervous system. Treatment for bph has long been medications and procedures such as lasers or an electric loop which burn the prostate from the inside out. Age related changes associated with metabolic disturbances changes in hormone balance and chronic inflammation may cause bph development. Presents with both storage symptoms frequency urgency nocturia and incontinence and voiding. Presents with both storage symptoms frequency urgency nocturia and incontinence and voiding. Role of phosphodiesterase 5 inhibitors.